DRG Fingertip insights
보험 플랜, 정책 제한, PBM, 의료 제공자 등 마켓 액세스 의사결정에 필요한 데이터와 인사이트를 제공합니다.
Formulary Advantages Among Hepatitis C Virus Therapies: Pharmacy directors do not yet understand the pharmacoeconomic incentives to cover emerging therapies
Hepatitis C virus (HCV) is the leading cause of end-stage liver disease and hepatocellular carcinoma. Increasing diagnosis and treatment rates, and substantial unmet need combine to make HCV a high-gr…